Good morning. It's Friday, July 10th, 2026.

China's space program just achieved first-stage recovery from an orbital launch — a milestone that, until today, only SpaceX had ever accomplished. On July 10th, at the Wenchang launch site in Hainan, a Long March 10B heavy-lift rocket reached orbit, and its first stage was successfully recovered at sea in a world-first net-capture operation. A specialized recovery vessel caught the descending booster using a cross-shaped wire net system — not the powered vertical touchdown that SpaceX's Falcon 9 performs, but still a major step. Before this, no country had recovered an orbital-class booster from an actual mission. The reusable ambition is clear: China is building the reusability infrastructure needed to deploy tens of thousands of Qianfan constellation satellites at lower cost. But the method matters — net capture gets you a booster back, while powered vertical landing enables rapid reflight. SpaceX has already flown the same Falcon 9 booster 36 times. China proved it can catch one; now comes the harder part: flying it again.

In medical robotics, researchers at UC San Diego have performed what they're calling the world's first live surgeries using teleoperated humanoid robots. The results, published in Nature on July 8th, used Unitree G1 humanoid robots — not Da Vinci-style surgical robots — to remove gallbladders from live pigs in a preclinical trial. A human surgeon at a remote console controlled the robot's arms in real time, and the team demonstrated both a human-robot pairing and a robot-robot team working side by side. The key distinction: these weren't autonomous. A surgeon's expertise was teleoperating the humanoid's hands. But it proves something important — that general-purpose humanoid platforms can be adapted for precision surgery, not just warehouse work or factory tasks. The researchers, led by Michael Yip, see this as a first step toward amplifying surgical access in underserved areas. Widespread clinical use is still years away, but the precedent is set: humanoids in medicine, not just manufacturing.

And in industrial robotics, Mitsubishi Motors announced a partnership with Highlanders, a University of Tokyo spinout, to develop and mass-produce humanoid robots for automotive manufacturing. The announcement came July 9th. Mitsubishi plans to start production at its Kyoto engine plant in early 2027, targeting 1,000 units per month. This is notable because it's the first time a major automaker has moved from piloting humanoid robots to actually building them — becoming both manufacturer and customer in one deal. Highlanders gets an operational partner and a production line; Mitsubishi gets custom-built humanoids tailored to its own factory workflows. It's a different model from the Tesla approach — no hype, no general-purpose sales pitch. Just a car company solving its own labor problem and potentially creating a new product line in the process. The humanoid supply chain is getting real, one factory at a time.

That's all for today. Have a good one.